XAGE

NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

Dollar change +0.02
Percentage change 0.83	%

Peers: SRDX MDXG AXGN RCEL OSUR VERO PAVM HSDT SENS

| Held by: VXF

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-11.60	Insider Own	16.20%	Shs Outstand	1.00M	Perf Week	-6.51%
Market Cap	2.45M	Forward P/E	-	EPS next Y	-	Insider Trans	0.00%	Shs Float	0.84M	Perf Month	-24.92%
Enterprise Value	2.20M	PEG	-	EPS next Q	-	Inst Own	3.58%	Short Float	1.45%	Perf Quarter	-38.34%
Income	-8.50M	P/S	4.38	EPS this Y	-	Inst Trans	-9.00%	Short Ratio	0.02	Perf Half Y	-71.88%
Sales	0.56M	P/B	-	EPS next Y	-	ROA	-180.78%	Short Interest	0.01M	Perf YTD	-70.86%
Book/sh	-3.79	P/C	3.18	EPS next 5Y	-	ROE	-	52W High	59.40 -95.89%	Perf Year	-95.04%
Cash/sh	0.77	P/FCF	-	EPS past 3/5Y	-270.08% -	ROIC	-	52W Low	2.20 10.91%	Perf 3Y	-99.16%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	17.90%	Volatility	7.10% 9.89%	Perf 5Y	-
Dividend TTM	-	EV/Sales	3.93	EPS Y/Y TTM	31.05%	Oper. Margin	-914.07%	ATR (14)	0.35	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	0.21	Sales Y/Y TTM	-	Profit Margin	-1516.61%	RSI (14)	41.33	Recom	-
Dividend Gr. 3/5Y	- -	Current Ratio	0.42	EPS Q/Q	75.85%	SMA20	-5.41%	Beta	0.49	Target Price	-
Payout	-	Debt/Eq	-	Sales Q/Q	-	SMA50	-27.56%	Rel Volume	0.02	Prev Close	2.42
Employees	15	LT Debt/Eq	-	Earnings	-	SMA200	-68.53%	Avg Volume	623.30K	Price	2.44
IPO	Sep 23, 2021	Option/Short	No / Yes	EPS/Sales Surpr.	- -	Trades		Volume	10,621	Change	0.83%

May-28-25 09:25AM	Longevity Health extends cash runway into 1Q26 (TipRanks) +12.55%
May-27-25 09:20AM	Longevity Health Holdings, Inc. Announces Successful Fundraising Via ATM Sale (GlobeNewswire) +10.50%
May-21-25 04:30PM	Longevity Health Holdings Announces Continued Nasdaq Listing to Complete Merger With 20/20 Biolabs (GlobeNewswire) -6.13% +12.75%
May-15-25 08:04AM	Longevity Health Holdings Announces Business Updates (GlobeNewswire) +10.18%
May-12-25 08:00AM	Longevity Health Holdings, Inc. Announces Reverse Stock Split (GlobeNewswire) -16.99%
08:03AM	Loading…
Apr-14-25 08:03AM	Longevity Health Holdings Announces Execution of Merger Agreement With 20/20 Biolabs (GlobeNewswire) +63.72%
Jan-16-25 08:00AM	Carmell Announces Closing of Elevai Skincare Acquisition (GlobeNewswire) +8.18%
Jan-03-25 08:00AM	Carmell Announces Closing of Previously Announced PIPE Investment from Existing and New Investors to Support Commercial Build-out (GlobeNewswire) -10.85%
Jan-02-25 08:00AM	Carmell Announces Execution of Definitive Agreement to Acquire Elevai Skincare, a leader in Physician Dispensed Exosome Skin and Hair Care Products (GlobeNewswire) +147.98%
Dec-24-24 08:30AM	Carmell Announces PIPE Investment From Existing and New Investors To Support Commercial Build-out (GlobeNewswire) +26.20%
Sep-05-24 08:30AM	Carmell Corporation Launches Skincare Partnership With Ladies Playbook to Support and Celebrate NFL Sports Community (GlobeNewswire) -11.29%
Jul-29-24 08:30AM	Carmell Corporation Appoints New CEO Following Addition to the Russell Microcap Index (GlobeNewswire) +13.00%
May-16-24 08:54AM	CTCX Stock Earnings: Carmell Therapeutics Reported Results for Q4 2023 (InvestorPlace)
Apr-11-24 04:30PM	Carmell Announces Successful Closing of $3.0 Million Private Placement (GlobeNewswire) -5.60%
Apr-04-24 08:30AM	Carmell Announces $3.0 Million Private Placement (GlobeNewswire) -9.72%
09:15AM	Loading…
Mar-27-24 09:15AM	Carmell Announces Successful Closing of Axolotl Biologix Sale Transaction (GlobeNewswire) -11.03%
Mar-20-24 04:39PM	Carmell Sharpens Aesthetics Focus with Execution of Definitive Agreement to Sell Axolotl Biologix Subsidiary (GlobeNewswire) +11.84% +5.84%
Mar-18-24 03:16PM	Carmell to Host Investor Webinar, Unveiling the Secretome: On the Eve of Product Launch Featuring Key Opinion Leaders in the Medical Aesthetics Field (GlobeNewswire)
Feb-26-24 08:30AM	Carmell Announces Product Development Completed for G.L.E.E. Launch in March 2024 (GlobeNewswire) +28.92%
Nov-16-23 08:30AM	Carmell Corp Announces Addition of Scott Frisch and Gilles Spenlehauer to Board of Directors (GlobeNewswire)
Sep-12-23 12:35PM	Moonshot Client Axolotl Announces Merger with Carmell Therapeutics, Elevating the Field of Regenerative Medicine (PR Newswire)
Sep-05-23 06:03PM	Carmell Corporation Announces Completion of Post-Merger Integration with Axolotl Biologix and New Organizational Structure Aligned with Focus on Aesthetics (GlobeNewswire) +17.60%
Aug-09-23 03:41PM	Carmell Announces Successful Closing of Merger with Axolotl Biologix and Launch of a New Brand Identity (Business Wire)
Jul-27-23 07:00AM	Carmell Therapeutics Announces Merger with Axolotl Biologix, a Profitable Regenerative Medicine Company (Business Wire) +46.00%

Longevity Health Holdings, Inc. is a regenerative medicine biotech company, which focuses on leveraging its core platform technology plasma based bioactive material to stimulate tissue repair or growth after severe injury, disease or aging. Its cosmetic product lines include Carmell Secretome and Elevai Exosomes, that support skin and hair health. The company was founded on November 5, 2008 and is headquartered in Pittsburgh, PA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Upton Richard A	Director	Sep 13 '24	Buy	0.47	5,000	2,336	15,000	Sep 16 04:30 PM
Gregory Kathryn	Director	Sep 06 '24	Buy	0.51	1,260	643	22,500	Sep 10 04:30 PM
Sturgeon Patrick A	Director	Sep 06 '24	Buy	0.51	1,261	643	18,051	Sep 10 04:30 PM
Cassaday Bryan J.	Chief Financial Officer	Sep 10 '24	Buy	0.46	475	218	4,250	Sep 10 04:30 PM
Frisch Scott M.	Director	Sep 06 '24	Buy	0.51	1,009	515	7,598	Sep 10 04:30 PM
Spenlehauer Gilles	Director	Sep 06 '24	Buy	0.51	1,009	515	7,598	Sep 10 04:30 PM
Gregory Kathryn	Director	Aug 30 '24	Buy	0.57	109	62	21,240	Sep 04 06:26 PM
Frisch Scott M.	Director	Aug 30 '24	Buy	0.57	87	50	6,589	Sep 04 04:51 PM
Sturgeon Patrick A	Director	Aug 30 '24	Buy	0.57	109	62	16,790	Sep 04 04:39 PM
Spenlehauer Gilles	Director	Aug 30 '24	Buy	0.57	87	50	6,589	Sep 04 04:34 PM
Sturgeon Patrick A	Director	Aug 28 '24	Buy	0.56	970	543	16,029	Aug 30 04:30 PM
Sturgeon Patrick A	Director	Aug 29 '24	Buy	0.56	652	365	16,681	Aug 30 04:30 PM
Frisch Scott M.	Director	Aug 28 '24	Buy	0.56	599	335	5,980	Aug 30 04:30 PM
Frisch Scott M.	Director	Aug 29 '24	Buy	0.56	522	292	6,502	Aug 30 04:30 PM
Gregory Kathryn	Director	Aug 28 '24	Buy	0.56	1,084	607	20,479	Aug 30 04:30 PM
Gregory Kathryn	Director	Aug 29 '24	Buy	0.56	652	365	21,131	Aug 30 04:30 PM
Cassaday Bryan J.	Chief Financial Officer	Aug 29 '24	Buy	0.57	1,000	570	3,775	Aug 30 04:30 PM
Anderson David W	Director	Aug 28 '24	Buy	0.56	749	419	7,476	Aug 30 04:30 PM
Anderson David W	Director	Aug 29 '24	Buy	0.56	652	365	8,128	Aug 30 04:30 PM
Spenlehauer Gilles	Director	Aug 28 '24	Buy	0.56	599	335	5,980	Aug 30 04:30 PM
Spenlehauer Gilles	Director	Aug 29 '24	Buy	0.56	522	292	6,502	Aug 30 04:30 PM
Gregory Kathryn	Director	Aug 27 '24	Buy	0.71	2,413	1,713	19,395	Aug 29 05:19 PM
Sturgeon Patrick A	Director	Aug 27 '24	Buy	0.71	1,587	1,127	15,059	Aug 29 05:17 PM
Sturgeon Patrick A	Director	Aug 26 '24	Buy	0.72	1,587	1,143	13,472	Aug 26 07:59 PM
Sturgeon Patrick A	Director	Aug 23 '24	Buy	0.72	1,587	1,143	11,885	Aug 26 07:59 PM
Gregory Kathryn	Director	Aug 26 '24	Buy	0.72	2,413	1,737	16,981	Aug 26 07:58 PM
Gregory Kathryn	Director	Aug 23 '24	Buy	0.72	2,413	1,737	14,568	Aug 26 07:58 PM
Sturgeon Patrick A	Director	Aug 21 '24	Buy	0.08	1,984	157	8,711	Aug 23 05:25 PM
Gregory Kathryn	Director	Aug 21 '24	Buy	0.79	3,016	2,389	9,743	Aug 23 05:08 PM
Gregory Kathryn	Director	Aug 22 '24	Buy	0.72	2,413	1,737	12,156	Aug 23 05:08 PM
Upton Richard A	Director	Aug 20 '24	Buy	0.89	3,600	3,218	10,000	Aug 21 05:57 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

Longevity Health Holdings Inc

Upgrade your FINVIZ experience